Trials / Not Yet Recruiting
Not Yet RecruitingNCT06720701
Development of Prognostic Models for Response and Toxicity to CAR-T Cell Therapy in Patients with Relapsed/refractory Non Hodgkin's Lymphoma.
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 125 (estimated)
- Sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Observational, single-center, tissue-based cohort study involving both retrospective and prospective enrollment of patients undergoing CAR-T cell therapy and up to 1 year of prospective follow-up necessary to detect the outcomes required by the study
Detailed description
This is a pharmacological observational study, with collection of biological material, single-centre, no-profit, involving both retrospective and prospective enrolment of patients undergoing CAR-T cell therapy and up to 1 year of prospective follow-up necessary to detect the outcomes required by the study.
Conditions
Timeline
- Start date
- 2024-12-01
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
- First posted
- 2024-12-06
- Last updated
- 2024-12-06
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06720701. Inclusion in this directory is not an endorsement.